HitGen Inc. (SHA:688222)
China · Delayed Price · Currency is CNY 35.20
-1.94 (-5.22%)
Oct 22, 2026, 4:00 PM EDT
HitGen Market Cap
HitGen has a market cap or net worth of 14.1 billion as of October 22, 2026. It is the 6,324th most valuable company in the world and the 1,100th biggest in China. Its market cap has increased by 53.19% in one year.
Market Cap
14.10B
Enterprise Value
13.45B
Revenue
644.54M
Global Rank
Country Rank
#1,100 China
PE Ratio
100.16
ChartMarket Cap Chart
Since April 16, 2020, HitGen's market cap has decreased from 18.86B to 14.10B, a decrease of -25.23%. That is a compound annual growth rate of -4.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 14.10B | 50.57% |
| Dec 31, 2025 | 9.37B | 90.34% |
| Dec 31, 2024 | 4.92B | -17.81% |
| Dec 29, 2023 | 5.99B | 10.86% |
| Dec 30, 2022 | 5.40B | -42.61% |
| Dec 31, 2021 | 9.41B | -22.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xiamen Amoytop Biotech | 18.77B |
| Hebei Changshan Biochemical Pharmaceutical | 18.52B |
| Yili Chuanning Biotechnology | 17.79B |
| Evopoint Biosciences | 17.75B |
| Acrobiosystems | 16.34B |
| Sinocelltech Group | 16.04B |
| Jinyu Bio-technology | 13.84B |
| BrightGene Bio-Medical Technology | 13.80B |